Rep. Kelly Introduces MAGIC Act to Make Generic Insulin a Reality
September 10, 2019
September 10, 2019
WASHINGTON, Sept. 10 -- Rep. Mike Kelly, R-Pennsylvania, issued the following news release:
Today, U.S. Representative Mike Kelly, R-Pa., vice-chair of the Diabetes Caucus and a diabetic himself, unveiled H.R. 4244, the Market Access for Generic Insulin Competition (MAGIC) Act of 2019. If enacted, this bill would pave the way for the approval and production of true, affordable generic insulin (and its analogues) for American diabetics.
"The average annual cost of i . . .
Today, U.S. Representative Mike Kelly, R-Pa., vice-chair of the Diabetes Caucus and a diabetic himself, unveiled H.R. 4244, the Market Access for Generic Insulin Competition (MAGIC) Act of 2019. If enacted, this bill would pave the way for the approval and production of true, affordable generic insulin (and its analogues) for American diabetics.
"The average annual cost of i . . .